Danaher Corporation $DHR Stock Acquired by Financial Enhancement Group LLC

Financial Enhancement Group LLC increased its stake in shares of Danaher Corporation (NYSE:DHR – Free Report) by 57.9% in the third quarter, Holdings Channel.com reports. The fund owned 18,169 shares of the conglomerate’s stock after purchasing an additional 6,665 shares during the period. Financial Enhancement Group LLC’s holdings in Danaher were worth $4,025,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Veery Capital LLC lifted its stake in Danaher by 3.1% in the 3rd quarter. Veery Capital LLC now owns 1,581 shares of the conglomerate’s stock worth $350,000 after purchasing an additional 48 shares in the last quarter. Studio Investment Management LLC increased its holdings in shares of Danaher by 3.3% in the second quarter. Studio Investment Management LLC now owns 1,581 shares of the conglomerate’s stock worth $302,000 after purchasing an additional 51 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd lifted its position in Danaher by 71.6% during the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after purchasing an additional 53 shares during the last quarter. JDH Wealth Management LLC lifted its position in Danaher by 4.5% during the first quarter. JDH Wealth Management LLC now owns 1,264 shares of the conglomerate’s stock valued at $240,000 after purchasing an additional 55 shares during the last quarter. Finally, OLD Second National Bank of Aurora grew its stake in shares of Danaher by 0.5% in the 1st quarter. OLD Second National Bank of Aurora now owns 12,114 shares of the conglomerate’s stock worth $2,297,000 after buying an additional 57 shares in the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts have recently issued reports on the stock. Guggenheim upped their target price on shares of Danaher from $200.00 to $250.00 and gave the company a “buy” rating in a research report on Thursday, October 1st. Barclays boosted their price objective on Danaher from $230.00 to $255.00 and gave the stock an “overweight” rating in a research note on Wednesday. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $240.00 price objective on shares of Danaher in a research report on Wednesday, July 22nd. UBS Group initiated coverage on Danaher in a research note on Wednesday, September 9th. They issued a “buy” rating and a $250.00 price objective for the company. Finally, The Goldman Sachs Group boosted their target price on Danaher from $210.00 to $250.00 and gave the company a “buy” rating in a research report on Monday, September 21st. Two analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $235.23.

Check Out Our Latest Analysis on DHR

Danaher Trading Down 0.5%

Shares of DHR stock traded down $1.16 during trading hours on Thursday, reaching $217.33. 5,292,542 shares of the stock were exchanged, compared to its average volume of 4,464,317. The firm has a market capitalization of $152.78 billion, a price-to-earnings ratio of 38.60, a price-to-earnings-growth ratio of 2.68 and a beta of 0.76. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The company’s 50-day moving average price is $210.88 and its 200-day moving average price is $194.44. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHR – Get Free Report) last posted its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The company had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm’s revenue for the quarter was up 5.5% on a year-over-year basis. During the same period in the prior year, the company posted $0.77 EPS. As a group, equities analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be issued a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Wednesday, September 30th. Danaher’s dividend payout ratio is presently 28.42%.

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.

Featured Articles

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.